Skip to content

ROGGEN APO

Active
Private limited companyfounded 20242 yrs activeBrusselstraat 322, 1702 Dilbeek, BelgiumKBO/BCE: BE 1010.619.244

The computed 12-month bankruptcy probability of ROGGEN APO is 1.7% (moderate). The 2025 annual accounts show equity of €17k and a net result of €5k. Its solvency ranks better than 37% of 11206 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
60 / 100
Healthy
The score combines four axes. Every signal that weighs is under Signals.
Axes
Profitability100
Solvency44
Growth-
Stability67
Bankruptcy probability, 12 months
1.7% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €1k at 30 days acceptable
Liquidity tight (current ratio 1.33), and 75.1% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 2 years 0 10 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
24.9%
Return on assets
7.4%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-08-2026, 30 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 1 filing
Deviation from the deadline
2025
30 d late
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€17k
Total assets
€69k
Net result
€5k
Working capital
€17k

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Equity and liabilities €69k
Equity €17k
Debt €51k
Debt finances 75.1% of the balance-sheet total.
Key figures and ratios
2025 value
Solvency
24.9%
Current ratio
1.33
Quick ratio
1.33
Debt / equity
3.01
ROE
29.7%
ROA
7.4%
Debt
€51k
Debt ≤ 1 year
€51k
Income taxes
€1k
Filed annual accounts
As filed with the NBB · 2025
Balance sheet Code2025
Assets
Total assets20/58€69k
Current assets29/58€69k
Amounts receivable within one year40/41€43k
Trade receivables40€36k
Other amounts receivable41€8k
Cash at bank and in hand54/58€25k
Equity and liabilities
Total equity and liabilities10/49€69k
Equity10/15€17k
Contributions10/11€12k
Reserves13€5k
Distributable reserves133€5k
Amounts payable17/49€51k
Amounts payable within one year42/48€51k
Trade debts44€50k
Suppliers440/4€50k
Taxes, remuneration and social security45€1k
Taxes450/3€1k
Income statement Code2025
Other operating charges640/8€787
Gross operating margin9900€7k
Operating profit (loss)9901€6k
Financial income75/76B€952
Recurring financial income75€952
Financial charges65/66B€349
Recurring financial charges65€349
Profit (loss) for the period before taxes9903€6k
Income taxes67/77€1k
Profit (loss) for the period9904€5k
Profit (loss) for the period to be appropriated9905€5k
Appropriation of the result
Profit (loss) to be appropriated9906€5k
Transfer to equity691/2€5k
To other reserves6921€5k

The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2026
30-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 30 days late
NBB filing

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Dilbeek · 1 establishment unit since 2024
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Brusselstraat 3221702 Dilbeek
Ground area
1,005 m²
Building footprint
253 m²
Volume, LiDAR
1,389 m³
Parcel 23026C0283/00L000, Flanders · tallest building 10.9 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
ROGGEN APO
Brusselstraat 322, 1702 DilbeekWholesale of pharmaceutical and medical goods
since 20242.362.065.113
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
23026C0283/00L000 Flanders 1,005 m² 1 · 253 m² 10.9 m · 1 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 1,893 companies in sector 46460 we hold annual accounts for 1,113. 295 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded21-06-2024
Fiscal year end31-12
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filingAddress and cadastre registers

Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.